Department of Pharmaceutical Sciences, Federal University of Paraiba, 58051-900 João Pessoa, PB, Brazil.
Evid Based Complement Alternat Med. 2014;2014:604152. doi: 10.1155/2014/604152. Epub 2014 Jul 24.
Lung cancer is a disease with high morbidity and mortality rates. As a result, it is often associated with a significant amount of suffering and a general decrease in the quality of life. Herbal medicines are recognized as an attractive approach to lung cancer therapy with little side effects and are a major source of new drugs. The aim of this work was to review the medicinal plants and other living organisms with antitumor potential against lung cancer. The assays were conducted with animals and humans, and Lewis lung carcinoma was the most used experimental model. China, Japan, South Korea, and Ethiopia were the countries that most published studies of species with antitumor activity. Of the 38 plants evaluated, 27 demonstrated antitumor activity. In addition, six other living organisms were cited for antitumor activity against lung cancer. Mechanisms of action, combination with chemotherapeutic drugs, and new technologies to increase activity and reduce the toxicity of the treatment are discussed. This review was based on the NAPRALERT databank, Web of Science, and Chemical Abstracts. This work shows that natural products from plants continue to be a rich source of herbal medicines or biologically active compounds against cancer.
肺癌是一种发病率和死亡率都很高的疾病。因此,它通常与大量的痛苦和生活质量的普遍下降有关。草药被认为是一种治疗肺癌的有吸引力的方法,副作用小,是新药的主要来源。这项工作的目的是综述具有抗肿瘤潜力的药用植物和其他生物对抗肺癌的作用。这些检测是在动物和人类身上进行的,Lewis 肺癌是最常用的实验模型。中国、日本、韩国和埃塞俄比亚是发表具有抗肿瘤活性的物种研究最多的国家。在评估的 38 种植物中,有 27 种显示出抗肿瘤活性。此外,还有 6 种其他生物被引用具有抗肿瘤活性,对抗肺癌。讨论了作用机制、与化疗药物联合使用以及提高活性和降低毒性的新技术。本综述基于 NAPRALERT 数据库、Web of Science 和 Chemical Abstracts。这项工作表明,植物的天然产物仍然是对抗癌症的草药或生物活性化合物的丰富来源。